Practical hints for the diagnosis of mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system

被引:0
作者
Mattiolo, Paola [1 ,2 ,3 ]
机构
[1] Univ Verona, Dept Diagnost & Publ Hlth, Univ & Hosp Trust Verona, Sect Pathol, Piazzale LA Scuro 10, I-37134 Verona, Italy
[2] Heinrich Heine Univ, Dept Pathol, D-40225 Dusseldorf, Germany
[3] Univ Hosp Duesseldorf, D-40225 Dusseldorf, Germany
关键词
Mixed neuroendocrine-non-neuroendocrine neoplasm; Digestive system; Neuroendocrine neoplasm; Immunohistochemistry; CARCINOID-TUMORS; CLASSIFICATION; IMMUNOHISTOCHEMISTRY; PANCREAS;
D O I
10.4251/wjgo.v16.i11.4326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this editorial, a comment on the article by D & iacute;az-L & oacute;pez et al published in the recent issue of the 2024 is provided. We focus on the practical implications critical for providing a correct and complete diagnosis of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) in the gastrointestinal system. The diagnosis of MiNEN begins with the recognition of neuroendocrine features in one component of a biphasic tumor. The non-neuroendocrine counterpart can be virtually represented by any neoplastic type, even though the most frequent histologies are glandular and squamous. However, qualification of the neuroendocrine component requires histological and immunohistochemical confirmation. Neuroendocrine tumors are characterized by a peculiar architectural organization and bland nuclei with granular "salt and pepper" chromatin. Although neuroendocrine carcinomas have multiple and variable presentations, they typically show a solid or organoid architecture. The histological aspect needs to be confirmed by immunohistochemistry, and a diagnosis is confirmed whenever the expression of keratin and neuroendocrine markers is observed. Once both histopathological and immunohistochemical features of neuroendocrine neoplasms are identified, it is important to consider the three major pitfalls of MiNEN diagnostics: (1) Entrapment of neuroendocrine non-neoplastic cells within the tumor mass; (2) Differential diagnosis with amphicrine neoplasms; and (3) Differential diagnosis of tumors that partially express neuroendocrine markers. According to the current guidelines for diagnosing digestive MiNEN, each component must represent at least 30% of the entire neoplastic mass. Although the high-grade histopathological subtype frequently determines disease prognosis, both components can significantly affect prognosis. Thus, if one of the components, either neuroendocrine or non-neuroendocrine, does not fulfill the volumetric criteria, the guidelines still encourage reporting it. These strict criteria are essential for correctly recognizing and characterizing digestive MiNENs. This task is essential because it has prognostic relevance and substantial potential value for guiding further studies in this field. In the future, systematic analyses should be performed to validate or reconsider the current 30% cutoff value.
引用
收藏
页数:8
相关论文
共 51 条
  • [1] Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract Recommendations of Verona Consensus Meeting
    Adsay, Volkan
    Mino-Kenudson, Mari
    Furukawa, Toru
    Basturk, Olca
    Zamboni, Giuseppe
    Marchegiani, Giovanni
    Bassi, Claudio
    Salvia, Roberto
    Malleo, Giuseppe
    Paiella, Salvatore
    Wolfgang, Christopher L.
    Matthaei, Hanno
    Offerhaus, G. Johan
    Adham, Mustapha
    Bruno, Marco J.
    Reid, Michelle D.
    Krasinskas, Alyssa
    Kloeppel, Guenter
    Ohike, Nobuyuki
    Tajiri, Takuma
    Jang, Kee-Taek
    Roa, Juan Carlos
    Allen, Peter
    Fernandez-del Castillo, Carlos
    Jang, Jin-Young
    Klimstra, David S.
    Hruban, Ralph H.
    [J]. ANNALS OF SURGERY, 2016, 263 (01) : 162 - 177
  • [2] Amin MB., AJCC Cancer Staging Manual, V8th
  • [3] Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases
    Basturk, Olca
    Tang, Laura
    Hruban, Ralph H.
    Adsay, Volkan
    Yang, Zhaohai
    Krasinskas, Alyssa M.
    Vakiani, Efsevia
    La Rosa, Stefano
    Jang, Kee-Taek
    Frankel, Wendy L.
    Liu, Xiuli
    Zhang, Lizhi
    Giordano, Thomas J.
    Bellizzi, Andrew M.
    Chen, Jey-Hsin
    Shi, Chanjuan
    Allen, Peter
    Reidy, Diane L.
    Wolfgang, Christopher L.
    Saka, Burcu
    Rezaee, Neda
    Deshpande, Vikram
    Klimstra, David S.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (04) : 437 - 447
  • [4] Goblet cell adenocarcinoma of the appendix: an update and practical approach to diagnosis and grading
    Bell, Phoenix D.
    Pai, Reetesh K.
    [J]. HUMAN PATHOLOGY, 2023, 132 : 183 - 196
  • [5] Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
    Bellizzi, Andrew M.
    [J]. HUMAN PATHOLOGY, 2020, 96 : 8 - 33
  • [6] Bosman FT., 2010, WHO CLASSIFICATION T
  • [7] Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?
    Cattaneo, Laura
    Centonze, Giovanni
    Sabella, Giovanna
    Lagano, Vincenzo
    Angerilli, Valentina
    Pardo, Carlotta
    Bertani, Emilio
    Spada, Francesca
    Prinzi, Natalie
    Pusceddu, Sara
    Fassan, Matteo
    Fazio, Nicola
    Milione, Massimo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188
  • [8] CHEJFEC G, 1985, CANCER-AM CANCER SOC, V56, P2683, DOI 10.1002/1097-0142(19851201)56:11<2683::AID-CNCR2820561127>3.0.CO
  • [9] 2-L
  • [10] An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs
    Couvelard, Anne
    Cros, Jerome
    [J]. VIRCHOWS ARCHIV, 2022, 480 (06) : 1129 - 1148